Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anaphylaxis to Neuromuscular Blocking Agents and Pholcodine Exposure. Case-control Study

NCT02250729 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT02250729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02250729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anaphylaxis to Neuromuscular Blocking Agents and Pholcodine Exposure. Case-control Study
Lead sponsor
Central Hospital, Nancy, France
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2014
Completion date
July 31, 2020
Enrollment
1,020 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

neuromuscular blocking agents anaphylaxis